Rongce Zhao

No. 17, South Renmin Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.

Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.

Journal: The international journal of biochemistry & cell biology

Published: August 23, 2019

CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.

CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.

Journal: Acta biochimica et biophysica Sinica

Published: June 18, 2019

Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion Rate.

Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion Rate.

Journal: World journal of surgery

Published: September 30, 2018

Antitumor activity in colorectal cancer induced by hinokiflavone.

Antitumor activity in colorectal cancer induced by hinokiflavone.

Journal: Journal of gastroenterology and hepatology

Published: June 15, 2018

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.

Journal: Medicine

Published: March 23, 2017

Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.

Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.

Journal: Clinical and experimental medicine

Published: March 22, 2017

Antitumor immunity induced by VE-cadherin modified DC vaccine.

Antitumor immunity induced by VE-cadherin modified DC vaccine.

Journal: Oncotarget

Published: March 10, 2017

Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.

Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.

Journal: Gene

Published: February 10, 2017

Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis.

Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis.

Journal: Surgical endoscopy

Published: November 21, 2016

BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.

BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.

Journal: Cancer letters

Published: September 07, 2016

Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial.

Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial.

Journal: Medicine

Published: July 12, 2016

Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials.

Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials.

Journal: Tumori

Published: February 08, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026